![Grant Feng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Grant Feng first degree
Entity | Entity type | Industry | |
---|---|---|---|
Deutsche Bank AG (Hong Kong)
![]() Deutsche Bank AG (Hong Kong) Investment Banks/BrokersFinance Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller.
4
| Subsidiary | Investment Banks/Brokers | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Grant Feng via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
UBS Securities (Asia) Ltd.
![]() UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Investment Banks/Brokers | Analyst-Equity | |
Merrill Lynch Far East Ltd.
![]() Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
Deutsche Bank AG - Sucursal em Portugal
![]() Deutsche Bank AG - Sucursal em Portugal Major BanksFinance Deutsche Bank AG - Sucursal em Portugal provides banking services. Its products include accounts, credit cards, investments, loan, and insurance. The company was founded by Jaime Roque de Pinho D'Almeida in 1978 and is headquartered in Lisbon, Portugal. | Major Banks | Chairman | |
DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal | |
Deutsche Bank Nederland NV
![]() Deutsche Bank Nederland NV Regional BanksFinance Part of Deutsche Bank AG, Deutsche Nederland NV is a Dutch company that provides banking services. The company is based in Amsterdam, the Netherlands. Harold Leenen has been the CEO of the company since 2011. | Regional Banks | Chairman | |
Technische Universität Darmstadt | College/University | Graduate Degree | |
Asia-Pacific Committee of German Business (Germany)
![]() Asia-Pacific Committee of German Business (Germany) Miscellaneous Commercial ServicesCommercial Services Asia-Pacific Committee of German Business operates as a forum for the formulation and discussion of Asia-Pacific-related economic and political interests concerning German and Asian business. The company is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
University of Warwick | College/University | Undergraduate Degree | |
abrdn Alternative Investments Ltd.
![]() abrdn Alternative Investments Ltd. Investment ManagersFinance abrdn Alternative Investments Ltd. (AAI) is the wholly owned asset management subsidiary of Aberdeen Asset Investment Group Ltd. and their ultimate parent is abrdn Plc (LON: ABDN, ADR: SLFPF) in Great Britain. Formerly held by Lloyds Banking Group plc (LSE: LLOY), Aberdeen Asset Management plc entered into a strategic alliance with Lloyds Banking Group plc in 2013, acquiring AAI and their related private equity and infrastructure fund management businesses. Formerly known as Aberdeen Asset Investments Ltd., the firm was founded in 1964 and is headquartered in London. AAI provides investment solutions to private individuals, financial institutions, charities, investment trusts and corporate and local government pension funds in Great Britain and worldwide. | Investment Managers | Analyst-Equity | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
Treadwell Therapeutics, Inc.
![]() Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Softhale NV
![]() Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
University of Toronto | College/University | Undergraduate Degree | |
SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
invoX Pharma Ltd.
![]() invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Investment Officer |
Statistics
International
Hong Kong | 4 |
Germany | 4 |
United Kingdom | 4 |
United States | 3 |
Portugal | 2 |
Sectoral
Finance | 9 |
Consumer Services | 4 |
Health Technology | 4 |
Commercial Services | 3 |
Operational
Analyst-Equity | 5 |
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Chairman | 2 |
Undergraduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Werner Steinmüller | 7 |
Philip Duong | 7 |
Vitus Leung | 3 |
Edwin Kwok | 3 |
- Stock Market
- Insiders
- Grant Feng
- Company connections